These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27583691)

  • 21. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
    Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kline RM; Neudorf SM; Baron HI
    Pediatrics; 2007 Oct; 120(4):e1120-2. PubMed ID: 17893186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation.
    Sorà F; Chiusolo P; Metafuni E; Bellesi S; Giammarco S; Laurenti L; Ausoni G; Zini G; Bayer AJ; Mario B; Leone G; Sica S
    Leuk Res; 2011 Mar; 35(3):422-3. PubMed ID: 21093053
    [No Abstract]   [Full Text] [Related]  

  • 24. T-cell lymphoproliferative disorder following a full haplotype-mismatched haematopoietic stem cell transplant in a patient with acute myeloid leukaemia.
    Rhee CK; Rhee JH; Kim HJ; Choi SM; Kim YJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC; Ahn KJ
    Bone Marrow Transplant; 2005 Sep; 36(5):461-3. PubMed ID: 15968275
    [No Abstract]   [Full Text] [Related]  

  • 25. Donor-derived lymphomatoid papulosis in a stem-cell transplantation recipient.
    Camp BJ; Busam KJ; Brownell I; Koehne G; Hedvat C; Pulitzer MP
    J Clin Oncol; 2011 Dec; 29(35):e855-8. PubMed ID: 22042951
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia.
    Ganguly S; Carrum G; Nizzi F; Heslop HE; Popat U
    Am J Hematol; 2004 Jan; 75(1):48-51. PubMed ID: 14695632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
    Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
    Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Kanda Y; Kami M; Tanosaki R; Mineishi S; Ohira M; Takaue Y
    Bone Marrow Transplant; 2003 Jan; 31(1):65-7. PubMed ID: 12621510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis.
    Válková V; Polák J; Marková M; Vítek A; Hájková H; Sálek C; Procházka B; Cetkovský P; Trněný M
    Clin Transplant; 2013; 27(1):E21-9. PubMed ID: 23231003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia.
    Tsimberidou AM; Medina J; Earl M; Sierra M; Shriki JE; Bueso-Ramos C; Giralt S; Beran M; Giles FJ; Garcia-Manero G
    Bone Marrow Transplant; 2003 Mar; 31(5):413-4. PubMed ID: 12634736
    [No Abstract]   [Full Text] [Related]  

  • 31. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.
    Meshinchi S; Leisenring WM; Carpenter PA; Woolfrey AE; Sievers EL; Radich JP; Sanders JE
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):706-13. PubMed ID: 14652854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
    Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
    Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
    Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
    Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
    [No Abstract]   [Full Text] [Related]  

  • 34. Skin involvement in leukemia.
    Kumar L; Singh S; Gupta A; Agarwal S; Dua H; Karak A; Kochupillai V
    J Assoc Physicians India; 1989 Mar; 37(3):217-8. PubMed ID: 2670884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.
    Cordonnier C; Maury S; Esperou H; Pautas C; Beaune J; Rodet M; Lagrange JL; Rouard H; Beaumont JL; Bassompierre F; Glückman E; Kuentz M; Durand-Zaleski I
    Bone Marrow Transplant; 2005 Oct; 36(7):649-54. PubMed ID: 16044135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Kim DH; Lee NY; Suh JS; Lee KB
    Bone Marrow Transplant; 2003 Jun; 31(11):967-72. PubMed ID: 12774046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
    Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission.
    Fagioli F; Zecca M; Locatelli F; Lanino E; Uderzo C; Di Bartolomeo P; Berger M; Favre C; Rondelli R; Pession A; Messina C;
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):575-83. PubMed ID: 18799933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid sarcoma on the scalp of a patient with acute myeloid leukemia.
    Muniz DN; Vasconcellos RC; Ambrosano L; Pereira ESP
    An Bras Dermatol; 2019; 94(5):622-624. PubMed ID: 31777369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.